Ramesh Kumar - 06 Oct 2022 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Director
Signature
/s/ Ramesh Kumar by Jessica Crespo, his attorney-in-fact
Issuer symbol
OCGN
Transactions as of
06 Oct 2022
Net transactions value
-$5,940
Form type
4
Filing time
07 Oct 2022, 16:06:48 UTC
Previous filing
20 Jul 2022
Next filing
09 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCGN Common Stock Options Exercise $2,295 +4,500 $0.5100 4,500 06 Oct 2022 Direct
transaction OCGN Common Stock Sale $8,235 -4,500 -100% $1.83 0 06 Oct 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Options Exercise $0 -4,500 -50% $0.000000 4,500 06 Oct 2022 Common Stock 4,500 $0.5100 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal monthly installments over three years commencing on February 2, 2020, subject to continued service with Ocugen, Inc. on the applicable vesting dates.

Remarks:

Exhibit List: Exhibit 24.1 - Power of Attorney